,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1601467,409805,Comparative Toxicogenomics Database (CTD),"N6-[2-[5-(diethylamino)pentan-2-ylamino]-6-methyl-4-pyrimidinyl]-2-methylquinoline-4,6-diamine",C487513,NSC 23766,https://ctdbase.org/detail.go?type=chem&acc=C487513,4314.0,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314,MMP3,10090,Mus musculus (house mouse),NSC 23766 inhibits the reaction [doxorubicin results in increased expression of MMP3 mrna],,,PMID:28710503,https://www.ncbi.nlm.nih.gov/pubmed/28710503,28710503,,
1,1672223,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3483.0,IGFALS,https://ctdbase.org/detail.go?type=gene&acc=3483,,,3483,IGFALS,10116,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of IGFALS mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
2,1672224,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3484.0,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484,IGFBP1,9606,Homo sapiens (human),Thioacetamide results in increased expression of IGFBP1 mRNA,,,PMID:11793227,https://www.ncbi.nlm.nih.gov/pubmed/11793227,11793227,,
3,1672225,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,3484.0,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484,IGFBP1,10116,Rattus norvegicus (Norway rat),Halofuginone inhibits the reaction [thioacetamide results in decreased expression of IGFBP1 mrna]|thioacetamide results in decreased expression of IGFBP1 mRNA,,,PMID:14739098,https://www.ncbi.nlm.nih.gov/pubmed/14739098,14739098,,
4,1684179,5324360,Comparative Toxicogenomics Database (CTD),Picrasidine I,C000625506,picrasidine I,https://ctdbase.org/detail.go?type=chem&acc=C000625506,596.0,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Picrasidine I results in increased expression of BCL2 protein,,,PMID:34894061,https://www.ncbi.nlm.nih.gov/pubmed/34894061,34894061,,
5,1794681,5329102,Comparative Toxicogenomics Database (CTD),Sunitinib,D000077210,Sunitinib,https://ctdbase.org/detail.go?type=chem&acc=D000077210,92715.0,DPH7,https://ctdbase.org/detail.go?type=gene&acc=92715,,,92715,DPH7,9606,Homo sapiens (human),Sunitinib results in increased expression of DPH7 mRNA,,,PMID:31533062,https://www.ncbi.nlm.nih.gov/pubmed/31533062,31533062,,
6,1794685,5717801,Comparative Toxicogenomics Database (CTD),Salubrinal,C496827,salubrinal,https://ctdbase.org/detail.go?type=chem&acc=C496827,1026.0,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,10116,Rattus norvegicus (Norway rat),Salubrinal inhibits the reaction [etoposide results in increased expression of CDKN1A mrna],,,PMID:23690541,https://www.ncbi.nlm.nih.gov/pubmed/23690541,23690541,,
7,1794686,5717801,Comparative Toxicogenomics Database (CTD),Salubrinal,C496827,salubrinal,https://ctdbase.org/detail.go?type=chem&acc=C496827,1029.0,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029,CDKN2A,10116,Rattus norvegicus (Norway rat),Salubrinal inhibits the reaction [etoposide results in increased expression of CDKN2A mrna],,,PMID:23690541,https://www.ncbi.nlm.nih.gov/pubmed/23690541,23690541,,
8,1794687,5717801,Comparative Toxicogenomics Database (CTD),Salubrinal,C496827,salubrinal,https://ctdbase.org/detail.go?type=chem&acc=C496827,6374.0,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374,CXCL5,9606,Homo sapiens (human),Salubrinal results in decreased expression of CXCL5 mRNA,,,PMID:29053414,https://www.ncbi.nlm.nih.gov/pubmed/29053414,29053414,,
9,2093287,44520887,BindingDB,"Benzazepine derivative, 17",35710,"benzazepine derivative, 17",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35710,325.0,Vasopressin V1a receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=325,P37288,Vasopressin V1a receptor,552,AVPR1A,9606,Homo sapiens (human),,IC50 (nM),1700,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
10,2093288,44520888,BindingDB,"Benzazepine derivative, 15",35712,"benzazepine derivative, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35712,325.0,Vasopressin V1a receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=325,P37288,Vasopressin V1a receptor,552,AVPR1A,9606,Homo sapiens (human),,IC50 (nM),1200,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
11,2093289,44520888,BindingDB,"Benzazepine derivative, 15",35712,"benzazepine derivative, 15",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35712,326.0,Vasopressin V2 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=326,P30518,Vasopressin V2 receptor,554,AVPR2,9606,Homo sapiens (human),,IC50 (nM),63,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
12,2093300,44520889,BindingDB,"Benzazepine derivative, 16",35713,"benzazepine derivative, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35713,326.0,Vasopressin V2 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=326,P30518,Vasopressin V2 receptor,554,AVPR2,9606,Homo sapiens (human),,IC50 (nM),140,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
13,2093301,44520889,BindingDB,"Benzazepine derivative, 16",35713,"benzazepine derivative, 16",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35713,325.0,Vasopressin V1a receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=325,P37288,Vasopressin V1a receptor,552,AVPR1A,9606,Homo sapiens (human),,IC50 (nM),540,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
14,2093302,44520890,BindingDB,"Benzazepine derivative, 18",35716,"benzazepine derivative, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35716,325.0,Vasopressin V1a receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=325,P37288,Vasopressin V1a receptor,552,AVPR1A,9606,Homo sapiens (human),,IC50 (nM),45,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
15,2093303,44520890,BindingDB,"Benzazepine derivative, 18",35716,"benzazepine derivative, 18",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35716,326.0,Vasopressin V2 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=326,P30518,Vasopressin V2 receptor,554,AVPR2,9606,Homo sapiens (human),,IC50 (nM),18,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
16,2093304,44520891,BindingDB,"Benzazepine derivative, 19",35717,"benzazepine derivative, 19",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35717,326.0,Vasopressin V2 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=326,P30518,Vasopressin V2 receptor,554,AVPR2,9606,Homo sapiens (human),,IC50 (nM),97,PMID:10482466|DOI:10.1016/s0968-0896(99)00101-7,https://www.ncbi.nlm.nih.gov/pubmed/10482466|https://doi.org/10.1016/s0968-0896(99)00101-7,10482466,10.1016/s0968-0896(99)00101-7,
17,2083626,46907787,Comparative Toxicogenomics Database (CTD),"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate",C561695,(+)-JQ1 compound,https://ctdbase.org/detail.go?type=chem&acc=C561695,3939.0,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939,LDHA,9606,Homo sapiens (human),(+)-JQ1 compound results in increased expression of LDHA mRNA,,,PMID:27292261,https://www.ncbi.nlm.nih.gov/pubmed/27292261,27292261,,
18,2085618,71623052,Chemical Probes Portal,"[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur",BAY-826,BAY-826,https://www.chemicalprobes.org/bay-826,,TEK,,Q02763,Angiopoietin-1 receptor,7010,TEK,9606,Homo sapiens (human),Inhibitor,,"0.9 nM, 1.6 nM, 0.45 nM, 0.4 nM, 1.3",,,,,"www.doi.org/10.1111/jnc.13877, https://pubmed.ncbi.nlm.nih.gov/27787897/"
19,2093290,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,891.0,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891,CCNB1,9606,Homo sapiens (human),Ziyuglycoside II results in decreased expression of CCNB1 protein,,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
20,2093291,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,995.0,CDC25C,https://ctdbase.org/detail.go?type=gene&acc=995,,,995,CDC25C,9606,Homo sapiens (human),Ziyuglycoside II results in decreased expression of and results in increased phosphorylation of CDC25C protein,,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
21,2093292,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,983.0,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983,CDK1,9606,Homo sapiens (human),Ziyuglycoside II results in decreased expression of and results in increased phosphorylation of CDK1 protein|ziyuglycoside II results in decreased expression of CDK1 protein,,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
22,2093293,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,1026.0,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,9606,Homo sapiens (human),Ziyuglycoside II results in increased expression of CDKN1A protein,,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
23,2093294,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,355.0,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355,FAS,9606,Homo sapiens (human),MAPK8 mutant form inhibits the reaction [ziyuglycoside II results in increased expression of FAS protein]|ziyuglycoside II results in increased expression of FAS protein,,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
24,2093295,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,356.0,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356,FASLG,9606,Homo sapiens (human),Ziyuglycoside II results in increased expression of FASLG protein|mapk8 mutant form inhibits the reaction [ziyuglycoside II results in increased expression of FASLG protein],,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
25,2093296,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,5599.0,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,9606,Homo sapiens (human),MAPK8 mutant form inhibits the reaction [ziyuglycoside II results in increased expression of FAS protein]|mapk8 mutant form inhibits the reaction [ziyuglycoside II results in increased expression of BAX protein]|mapk8 mutant form inhibits the reaction [ziyuglycoside II results in increased expression of FASLG protein]|mapk8 mutant form inhibits the reaction [ziyuglycoside II results in decreased expression of BCL2 protein],,,PMID:24680927,https://www.ncbi.nlm.nih.gov/pubmed/24680927,24680927,,
26,2093297,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,142.0,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ziyuglycoside II results in increased cleavage of PARP1 protein,,,PMID:31029785,https://www.ncbi.nlm.nih.gov/pubmed/31029785,31029785,,
27,2093298,71773126,Comparative Toxicogenomics Database (CTD),ziyuglycoside II,C000588918,ziyuglycoside II,https://ctdbase.org/detail.go?type=chem&acc=C000588918,7157.0,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Ziyuglycoside II results in increased phosphorylation of TP53 protein,,,PMID:31029785,https://www.ncbi.nlm.nih.gov/pubmed/31029785,31029785,,
28,2093299,71777747,Chemical Probes Portal,4-(3-{4-[(R)-Amino(Cyclopentyl)phenylmethyl]piperidin-1-Yl}propoxy)benzonitrile,MIV-6R,MIV-6R,https://www.chemicalprobes.org/miv-6r,,KMT2A,,Q03164,Histone-lysine N-methyltransferase 2A,4297,KMT2A,9606,Homo sapiens (human),Menin-MLL PPI inhibitor,,85 nM,,,,,"http://pubs.acs.org/doi/abs/10.1021/jm401868d, http://www.ncbi.nlm.nih.gov/pubmed/?term=24472025"
